Victor Manuel Victor González-rekin lankidetzan egindako argitalpenak (24)

2022

  1. Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients

    Redox Biology, Vol. 53

2019

  1. Dietary weight loss intervention improves subclinical atherosclerosis and oxidative stress markers in leukocytes of obese humans

    International Journal of Obesity, Vol. 43, Núm. 11, pp. 2200-2209

  2. Does Glycemic Control Modulate the Impairment of NLRP3 Inflammasome Activation in Type 2 Diabetes?

    Antioxidants and Redox Signaling, Vol. 30, Núm. 2, pp. 232-240

  3. The SGLT2 inhibitor empagliflozin ameliorates the inflammatory profile in type 2 diabetic patients and promotes an antioxidant response in leukocytes

    Journal of Clinical Medicine, Vol. 8, Núm. 11

  4. The mitochondria-targeted antioxidant MitoQ modulates mitochondrial function and endoplasmic reticulum stress in pancreatic β cells exposed to hyperglycaemia

    Cellular Physiology and Biochemistry, Vol. 52, Núm. 2, pp. 186-197

2018

  1. Does Metformin Modulate Endoplasmic Reticulum Stress and Autophagy in Type 2 Diabetic Peripheral Blood Mononuclear Cells?

    Antioxidants and Redox Signaling, Vol. 28, Núm. 17, pp. 1562-1569

  2. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation

    Cellular Physiology and Biochemistry, Vol. 50, Núm. 3, pp. 1015-1028

  3. Mitochondrial DNA haplogroup JT is related to impaired glycaemic control and renal function in type 2 diabetic patients

    Journal of Clinical Medicine, Vol. 7, Núm. 8

  4. Obesity impairs leukocyte-endothelium cell interactions and oxidative stress in humans

    European Journal of Clinical Investigation, Vol. 48, Núm. 8

  5. The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Does Metformin Protect Diabetic Patients from Oxidative Stress and Leukocyte-Endothelium Interactions?

    Antioxidants and Redox Signaling, Vol. 27, Núm. 17, pp. 1439-1445

  2. Low testosterone levels are related to oxidative stress, mitochondrial dysfunction and altered subclinical atherosclerotic markers in type 2 diabetic male patients

    Free Radical Biology and Medicine, Vol. 108, pp. 155-162

  3. Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications

    Redox Biology, Vol. 11, pp. 637-645

  4. Oxidative and endoplasmic reticulum stress is impaired in leukocytes from metabolically unhealthy vs healthy obese individuals

    International Journal of Obesity, Vol. 41, Núm. 10, pp. 1556-1563

2016

  1. Are Mitochondrial Fusion and Fission Impaired in Leukocytes of Type 2 Diabetic Patients?

    Antioxidants and Redox Signaling, Vol. 25, Núm. 2, pp. 108-115

  2. Atherosclerosis, Mitochondrial Dysfunction and Oxidative Stress: Mitochondria-Targeted Anti-oxidants as Potential Therapy

    Frontiers in Medicinal Chemistry (Bentham Science Publishers), pp. 96-135

  3. Effects of simvastatin, ezetimibe and simvastatin/ezetimibe on mitochondrial function and leukocyte/endothelial cell interactions in patients with hypercholesterolemia

    Atherosclerosis, Vol. 247, pp. 40-47

  4. Insulin resistance in PCOS patients enhances oxidative stress and leukocyte adhesion: Role of myeloperoxidase

    PLoS ONE, Vol. 11, Núm. 3

  5. Mitochondrial dysfunction and endoplasmic reticulum stress in diabetes

    Current Pharmaceutical Design, Vol. 22, Núm. 18, pp. 2640-2649

  6. Role of oxidative stress and mitochondrial dysfunction in skeletal muscle in type 2 diabetic patients

    Current Pharmaceutical Design, Vol. 22, Núm. 18, pp. 2650-2656